Suchergebnisse - (Subject:"Tocilizumab")

PubPharm (513)

1

Tocilizumab for refractory post-COVID-19 pansclerotic morphea

enthalten in: Journal of the European Academy of Dermatology and Venereology : JEADV | 2024

von Saraswat, N. | Tripathy, D. | Mishra, A. | +3

2

Pulmonary alveolar proteinosis in an adult patient affected by Still's disease and recurrent episodes of macrophage activation syndrome

enthalten in: Joint bone spine | 2024

von Bindoli, S. | Lococo, S. | Calabrese, F. | +1

3

Tocilizumab and hyperdynamic syndrome in severe burn patient : is that pouring water on fire?

enthalten in: Italian journal of dermatology and venereology | 2023

von Coletta, F. | Sala, C. | Tomasello, A. | +1

4

Prophylactic tocilizumab to prevent cytokine release syndrome (CRS) with teclistamab : A single-center experience

enthalten in: Blood cancer journal | 2023

von Scott, S. | Marin, E. | Maples, K. | +7

5

Interleukin-6 inhibition for the treatment of IgG4 related vasculitis

enthalten in: European journal of internal medicine | 2023

von Batani, V. | Minici, C. | Sanvito, F. | +3

6

The key data from the 2022 European Thyroid Association congress : Toward personalized treatment of Graves' orbitopathy

enthalten in: Annales d'endocrinologie | 2023

von Abeillon-du Payrat, J. | Caron, P.

7

Risk of Thrombosis With the Use of Tocilizumab in Patients With COVID-19

enthalten in: The Annals of pharmacotherapy | 2023

von Kow, C. | Ramachandram, D. | Hasan, S.

CommentOn: Ann Pharmacother. 2023 Jul;57(7):769-775. - PMID 36314277

8

Comment : Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19

enthalten in: The Annals of pharmacotherapy | 2023

von Mungmunpuntipantip, R. | Wiwanitkit, V.

CommentOn: Ann Pharmacother. 2023 Jul;57(7):769-775. - PMID 36314277

9

Administration of tocilizumab in septic patients with pancytopenia and hyper-inflammatory syndrome

enthalten in: Annals of hematology | 2023

von Tomulic Brusich, K. | Juricic, K. | Bobinac, M. | +3

CommentOn: Ann Hematol. 2023 Apr;102(4):961-966. - PMID 36864209

10

Reply : Baricitinib Versus Tocilizumab for the Treatment of Moderate to Severe COVID-19

enthalten in: The Annals of pharmacotherapy | 2023

von Lewis-Wolfson, T. | Joyner, K.

CommentOn: Ann Pharmacother. 2023 Jul;57(7):769-775. - PMID 36314277

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[52]